Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
taxus baccata/kemoterapija
Veza se sprema u međuspremnik
14 rezultatima
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Docetaxel, a semisynthetic analog of paclitaxel, made for the needles of the European yew, Taxus baccata, is a potentially important chemotherapeutic agent for the treatment of cancer.
METHODS
In a phase II study patients with advanced and/or metastatic breast cancer and bidimensionally
[Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Docetaxel (Taxotere) is a taxoid derived from the European yew tree, taxus baccata. In 4 phase-II studies docetaxel has important single agent activity with an overall prostate-specific antigen response rate of 42% in hormone refractory prostate cancer. Other phase-II studies suggest that the
[Current approaches in the medical treatment of advanced ovarian carcinoma].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Ovarian cancer is most frequently diagnosed at an advanced stage. In recent years there has been intense interest in the chemotherapy of this disease. About cisplatin, the most active agent in the treatment of advanced ovarian cancer, some questions are only partially answered, as the optimal dose,
Docetaxel: a new active agent in the therapy of metastatic breast cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Breast cancer is the most common malignancy in women, accounting for about 18% of female cancers, and over half a million new cases are diagnosed worldwide each year. Its incidence increases with age and is currently rising. Although the increased availability of screening programs has allowed
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A late phase II clinical trial of RP56976 (docetaxel), derived from Taxus baccata was performed to evaluate anti-tumour activity, time to progression and clinical toxicity in patients with advanced or recurrent breast cancer. The patients, between 15 and 80 years old with performance status (PS) of
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
N-Debenzoyl-N-tert-butoxycarbonyl-10-deacytyl taxol (Taxotere, RP 56976) is a semisynthetic analogue of taxol, prepared from a noncytotoxic precursor extracted from the needles of the European yew tree (Taxus baccata L.). It has a broad spectrum of antitumor activity against a variety of
Preclinical evaluation of docetaxel (Taxotere).
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Progress in cancer chemotherapy has been made owing to the discovery and development of drugs that have new structures, new mechanisms of action, and high levels of experimental antitumor activity. Docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is prepared by semisynthesis from
Docetaxel (taxotere) in the treatment of non-small cell lung cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Docetaxel is a new semi-synthetic anticancer agent derived from bacatin III of the needles of the European yew Taxus baccata. Docetaxel has a novel mechanism of action since it binds to tubulin inducing its polymerization and promoting stable microtubule formation. Several differences exist between
Docetaxel (Taxotere) in combination: a step forward.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is a hemisynthetic derivative from European yew that inhibits tubulin depolymerization and enhances the formation of microtubule bundle aggregates, causing cell death. Activity against a variety of tumor types has been reported. Single-agent
Current status of Taxotere (docetaxel) as a new treatment in breast cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Therapy for advanced breast cancer has not improved significantly in recent years, remaining strictly palliative in nature and intent. One approach to increase the effectiveness of the treatment is the introduction of active new drugs. Taxotere (docetaxel) is a taxoid derivative isolated from the
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Docetaxel (Taxotere) is prepared from a noncytotoxic precursor extracted from the needles of the Taxus baccata. Preclinical investigations have demonstrated that docetaxel is very active in colon adenocarcinoma murine models. Phase I studies revealed granulocytopenia to be the
Benefit risk assessment and update on the use of docetaxel in the management of breast cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The objective of this paper is to review the data supporting the use of docetaxel in the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant and metastatic trials alone and in combination with chemotherapeutic and targeted agents, and the toxicity of docetaxel in
Production of the anticancer drug taxol by the endophytic fungus Epicoccum nigrum TXB502: enhanced production by gamma irradiation mutagenesis and immobilization technique
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Taxol, a phyto-extracted diterpenoid, is the most commercially needed drug in cancer chemotherapy. In spite of the microbial production of taxol being successful and prospective, the reported yields are still not sufficient for large-scale production. Thus, the discovery of new taxol-producing
Update on taxane development: new analogs and new formulations.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The taxanes (paclitaxel and docetaxel) represent an important class of antineoplastic agents that interfere with microtubule function leading to altered mitosis and cellular death. Paclitaxel (Taxol(®)) was originally extracted from a yew tree (Taxus spp., Taxaceae) a small slow-growing evergreen,
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
